KELLY IQBAL: Open Payments
NPI 1700219862 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 115 payments from 19 companies in 2025. Trend: 2023 $2,094 · 2024 $1,914 · 2025 $2,018
Food & beverage: $2,018
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 30 | $377 |
| PFIZER INC. | 17 | $219 |
| AstraZeneca Pharmaceuticals LP | 9 | $217 |
| ABBVIE INC. | 8 | $185 |
| Novartis Pharmaceuticals Corporation | 10 | $182 |
| ANI Pharmaceuticals, Inc. | 6 | $133 |
| Janssen Biotech, Inc. | 5 | $123 |
| Lilly USA, LLC | 5 | $101 |
| UCB, Inc. | 3 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $78 |
Products named: LEQVIO, PURIFIED CORTROPHIN GEL, AIRSUPRA, OTEZLA, TREMFYA, NURTEC ODT, EVENITY, Bimzelx.
Industry payments across MO — which companies pay providers there.
